NAVIGATION
Pharmacovigilance Strategy Meeting USA East Coast 2017

Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Pharmacovigilance.

Register Now
7th November 2017, The Westin Boston Waterfront
2017-11-7 7:30:00 2017-11-7 18:30:00 America/New_York Pharmacovigilance Strategy Meeting USA East Coast 2017 7th November 2017, The Westin Boston Waterfront Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Pharmacovigilance. https://proventainternational.com/pharmacovigilance-us/ The Westin Boston Waterfront Althea Mapala am@proventainternational.com

Agenda

The Pharmacovigilance Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Pharmacovigilance (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities.

Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Pharmacovigilance, Risk Management, Drug Safety, Safety Surveillance, Clinical Safety, Patient Safety, Medical & Regulatory Affairs, Compliance, Post Authorisation Safety, Medical Safety, Epidemiology.

Those who do not qualify for complimentary passes, including vendors, exchanges, consultancies and other service providers, can apply here.

Pharmacovigilance Meeting USA 2017

DOWNLOAD AGENDA

Advisory Board

Testimonials

 

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger, VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division,Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager,EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO,Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

,

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger, VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division,Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager,EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO,Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Location

The Westin Boston Waterfront 425 Summer St, Boston, MA 02210
United States

Date: Nov 07,2017 - Nov 07,2017 Time:7:30AM – 9:00PM.

Book your seat for the Pharmacovigilance Meeting USA 2017

DELEGATE REGISTRATION